Clinical use of AO retinal imaging: Symposium at EVER 2018
The 2018 congress of the European Association for Vision and Eye Research will feature a symposium fully dedicated to Adaptive Optics retinal imaging. On October 5th, in Nice, France, a panel of experts will present about cellular resolution retinal imaging such as with the rtx1 AO retinal camera. They will show how it has brought new relevant insights into the retina, in various diseases and treatments.
Many thanks to speakers and visitors at Euretina 2018 !
Imagine Eyes’ team wishes to thank all the congress attendees who visited our booth at the Euretina 2018 meeting in Vienna last week. We hope that everyone enjoyed our live demonstrations of cellular resolution retinal imaging, as well as our new high-precision follow-up functionality.
We are also very grateful to Pr Masayo Takahashi (Kobe Eye Center, Hyogo, Japan) and Pr Kiyoko Gocho (Nippon Medical School, Chiba, Japan) for presenting clinical results obtained with the rtx1 Adaptive Optics Retinal Camera.
New publication highlights the benefits of Adaptive Optics retinal imaging in retinal degeneration and chronic vascular conditions
Ophthalmic examinations using adaptive optics reveal structural details in the retina that remain invisible with conventional imaging. Prof Michel Paques and his team at France’s National Ophthalmology Center in Paris recently published an article which explains how adaptive optics has provided relevant new insights on the retina in a wide range of diseases. Read more
Special autumn course on Adaptive Optics retinal imaging in Paris – October 8, 2018
What is adaptive optics (AO)? How to use its full potential in retinal imaging? How to interpret AO images in case of pathology ? If you are curious about these questions, come to Paris, France, on October 8th 2018 and attend the first 1-day course fully dedicated to AO retinal imaging. Registration is open ! Read more
Latest progress in retinal imaging discussed during H2020 MERLIN project meeting
The consortium of European industrial, scientific and medical partners met last week in Vienna, Austria, for their 6-month progress review on the MERLIN project. A real synergy between clinicians and scientists arised as the partners shared their latest advances on:
- Optical coherence tomography (OCT),
- Adaptive Optics imaging,
- Image registration,
- System integration.
Case study using rtx1 reveals reduced photoreceptor density in atypical Usher syndrome
The Usher syndrome is one of the most common types of retinitis pigmentosa, an inherited retinal disorder with an estimated prevalence between 1:3000 and 1:5000. Patients with Usher syndrome usually suffer from losses in both hearing and vision. However, in some patients, mutations in the CEP250 gene cause an atypical Usher syndrome, where ophthalmological symptoms are mild, thus difficult to detect using conventional retinal imaging techniques.
ISCEV 2018: presentation on imaging cell loss in inherited retinal disease using the rtx1
Clinical results obtained with the rtx1 Adaptive Optics Camera will be presented at the International Society for Clinical Electrophysiology of Vision symposium on June 21st, 2018, in Reims, France. Read more
Study shows that adaptive optics findings in the retina might help prevent cardiovascular events
As cardiovascular events are a leading cause of death, their prevention is of key importance to public health. In the past, two longitudinal studies demonstrated that analyzing the wall morphology of small arteries could improve the prediction of such serious events. Unfortunately, in both studies, the measurement technique required extracting small blood vessels from under the skin. The invasive nature of these examinations has prevented further application in clinical routine.
Imagine Eyes appoints Barbara Lamory-Bardet as Manager of Quality and Regulatory Affairs
We are happy to announce that Mrs Barbara Lamory-Bardet has been appointed as Manager of Quality and Regulatory Affairs (QRA) at Imagine Eyes®. In this new position, Barbara will direct quality management as well as all compliance and certification activities. “I am grateful to Barbara for taking up this new challenge. No doubt that her extensive skills and firm determination will quickly result in expanding our market access and international reach” says Nicolas Chateau, CEO at Imagine Eyes.
rtx1 : new clinical results in vascular imaging at ESH 2018
rtx1 users will be presenting new clinical results at the upcoming European Society of Hypertension meeting in Barcelona, in June 8-11.